|  | 
| MechanismTRPV1 antagonists | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Purdue Pharma, Inc.
0  Patents (Medical) associated with Purdue Pharma, Inc.
100 Deals associated with Purdue Pharma, Inc.
100 Translational Medicine associated with Purdue Pharma, Inc.